Evidence map›Paper›PMID 33194649›Full record

ReviewFrontiers in oncology2020

The Current State of Radiomics for Meningiomas: Promises and Challenges.

Hao Gu, Xu Zhang, Paolo di Russo, Xiaochun Zhao, Tao Xu

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 46 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Research on imaging biomarkers for chronic subdural hematoma recurrence.Medical & biological engineering & computing · 2025
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Dosimetric variability across a library of computational tumor phantoms.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2023
    Article
  17. Surgeon's Eyes on the Relevant Surgical Target.Acta neurochirurgica. Supplement · 2023
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

Hao GuDepartment of Neurosurgery, Changzheng Hospital, Naval Medical University, Shanghai, China.
Xu ZhangDepartment of Neurosurgery, Changzheng Hospital, Naval Medical University, Shanghai, China.
Paolo di RussoDepartment of Neurosurgery, I.R.C.C.S. Neuromed, Pozzilli, Italy.
Xiaochun ZhaoDepartment of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
Tao XuDepartment of Neurosurgery, Changzheng Hospital, Naval Medical University, Shanghai, China.
Second Military Medical University · CNIstituto Neurologico Mediterraneo · ITShanghai Changzheng Hospital · CNUniversity of Oklahoma Health Sciences Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Meningiomas are the most common primary tumors of the central nervous system. Given the fact that the majority of meningiomas are benign, the preoperative risk stratification and treatment strategy decision-making highly rely on the conventional subjective radiologic evaluation. However, this traditional diagnostic and treatment modality may not be effective in patients with aggressive-growing tumors or symptomatic patients with potential risk of recurrence after surgical resection or radiotherapy, as this passive "wait and see" strategy could miss the optimal opportunity of intervention. Radiomics, a new rising discipline, translates high-dimensional image information into abundant mathematical data by multiple computational algorithms. It provides an objective and quantitative approach to interpret the imaging data, rather than the subjective and qualitative interpretation from relatively limited human visual observation. In fact, the enormous amount of information generated by radiomics analyses provides radiological to histopathological tumor information, which are visually imperceptible, and offers technological basis to its applications amid diagnosis, treatment, and prognosis. Here, we review the latest advancements of radiomics and its applications in the prediction of the pathological grade, pathological subtype, recurrence possibility, and differential diagnosis of meningiomas, and the potential and challenges in general clinical applications. In this review, we highlight the generalization of shared radiomic features among different studies and compare different performances of popular algorithms. At last, we discuss several possible aspects of challenges and future directions in the development of radiomic applications in meningiomas.

Indexed as

deep learningdiagnosismedical imagingmeningiomaradiomics

Identifiers

PMID33194649
PMCPMC7653049
OpenAlexW3095642462

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.